Commercial Lilly’s obesity pill off to a strong start; OpenAI debuts new drug discovery tool BioPharma DiveSome 1,390 Foundayo prescriptions were written in two days, according to analysts.CommercialMetabolic & GLP-1Read full story pharminent April 17, 2026 (Last updated: April 17, 2026) BioPharma Dive Some 1,390 Foundayo prescriptions were written in two days, according to analysts. CommercialMetabolic & GLP-1Read full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: Lilly’s Foundayo reaches 1,390 patients in first week, trailing Novo’s oral Wegovy launchNext: Kailera makes history with record-breaking $625m IPO Related Stories Commercial Post-marketing oncology studies: Enabling faster recruitment and lower costs pharminent June 22, 2026 Commercial The first 14 days: How specialty programs set patients up for success pharminent June 22, 2026 Commercial Denali sells FDA voucher for $195M to support neurodegenerative pipeline pharminent June 19, 2026
